Related Experiment Video

Updated: Apr 5, 2026

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
07:36

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea

Published on: December 23, 2022

2.0K

Prenylated Dihydrochalcones from Artocarpus altilis as Antiausterity Agents

Mai Thanh Thi Nguyen1, Nhan Trung Nguyen1, Suresh Awale2

  • 1Faculty of Chemistry, University of Science, Vietnam National University, Hochiminh City, Viet Nam.

The Enzymes
|August 24, 2015
PubMed

Insights

Breadfruit compounds show promise in fighting pancreatic cancer by inhibiting cancer cell survival under nutrient-deprived conditions, a key challenge in tumor microenvironments.

Area of Science:

  • Oncology
  • Pharmacognosy
  • Biochemistry

Background:

  • Human pancreatic cancer cells exhibit significant tolerance to nutrient starvation, aiding survival within the tumor microenvironment.
  • Anticancer drug discovery is exploring antiausterity strategies to target cancer cell survival under low nutrient conditions.
  • Artocarpus altilis (breadfruit) is traditionally used for various ailments and contains prenylated flavonoids and chalcones with reported cytotoxicity.

Purpose of the Study:

  • To summarize the constituents, biosynthesis, cytotoxicity, and antiausterity activity of Artocarpus altilis.
  • To evaluate the efficacy of A. altilis extracts against the PANC-1 human pancreatic cancer cell line under nutrient-deprived conditions.

Main Methods:

  • Phytochemical analysis of Artocarpus altilis constituents.
  • Assessment of cytotoxicity against PANC-1 cells.
  • Evaluation of antiausterity effects under starvation conditions.

Main Results:

  • Artocarpus altilis contains prenylated flavonoids and chalcones.
  • These compounds exhibit cytotoxicity against human pancreatic cancer cells.
  • The plant's extracts demonstrate antiausterity activity, inhibiting cancer cell survival under low nutrient conditions.

Conclusions:

  • Artocarpus altilis possesses compounds with significant anticancer properties.
  • The plant's antiausterity activity presents a novel strategy for pancreatic cancer drug discovery.
  • Further research into breadfruit constituents could lead to new therapeutic agents for pancreatic cancer.
Keywords:
Antiausterity activityArtocarpus altilisPancreatic cancerPrenylated dihydrochalcone

More Related Videos

Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of Syzygium aromaticum Clove and Cuminun cyminum Cumin on C57BL6/j Mice Fed High-Fat Diet13:09

Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of Syzygium aromaticum Clove and Cuminun cyminum Cumin on C57BL6/j Mice Fed High-Fat Diet

Published on: July 31, 2021

4.1K

Related Concept Videos

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
887
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
1.1K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
3.1K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.8K
Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.7K
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers01:17

Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers

Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
1.8K